Skip to content

Clinical validation of AVPR1A as a biomarker for intracranial aneurysms: a prospective cohort study

Clinical validation of AVPR1A as a biomarker for intracranial aneurysms: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129515
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-10-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

Case group:None
Control group:None

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for the case group: 1) Aged 18-75, of either gender; 2) Diagnosed with intracranial aneurysm through DSA or CTA examination; 3) Agree to participate in this study and sign the informed consent form; 4) Able to cooperate in completing sample collection and follow-up. 2. Inclusion criteria for the control group: 1) Aged 18-75, with no gender restrictions; 2) No history of intracranial aneurysm, and intracranial aneurysm has been excluded through imaging examination; 3) No other cerebrovascular diseases (such as cerebral arteriovenous malformation, moyamoya disease, etc.); 4) Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for the case group: 1) Co-existing with other central nervous system diseases (such as brain tumors, encephalitis, etc.); 2) Combined severe cardiac, hepatic, and renal insufficiencies; 3) Concurrent malignant tumor or undergoing radiotherapy and chemotherapy; 4) Have undergone major surgery within the past 3 months; 5) Pregnant or lactating women; 6) Participating in other clinical trials. 2. Exclusion criteria for the control group: 1) Those with uncontrolled vascular risk factors such as hypertension and diabetes; 2) History of autoimmune disease; 3) Having infectious diseases within the past month; 4) Pregnant or lactating women; 5) Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
AVPR1A protein content;AVPR1A mRNA content;Aneurysm characteristics;Ruptured aneurysm state;MRI vascular wall imaging;mRS score;

Secondary

MeasureTime frame
ANGPTL1 protein content;ANGPTL1 mRNA content;

Countries

China

Contacts

Public ContactJiang Wu

The First Affiliated Hospital of Soochow University

jiang.wu@neurosci.com.cn+86 512 6797 2117

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026